KROONIAPTEEK OÜ current status
This company's branding has already reached 443 peoplebut no user is tracking his activities.On average, the company has been rated 4.5 points.but there is no comment.
's activity report 2022
Company Description
The main activity of Krooniapteek OÜ is the retail trade of medicines and other pharmacy goods. Krooniapteek OÜ includes 5 pharmacies, one of which is a branch pharmacy.
In order to provide customers with high-level pharmacy services and to acquire expertise in the operation of the pharmacy, pharmacies use
HEART PHARMACY franchise concept and also operate under the HEART PHARMACY brand.
Sales
In the financial year 01.01.2022-31.12.2022, the total sales turnover of Krooniapteek OÜ pharmacies was 4,971.1 thousand EUR (the sales turnover of the 2021 financial year was 4,537.2 thousand EUR). The growth in sales turnover in 2022 was partly due to the fact that people used a lot of self-testing opportunities with Covid-19 rapid tests.
Significant events The invasion of Russian troops into Ukraine, which began on February 24, 2022, has not significantly affected the sales results of pharmacies.
Plans for the next financial year
In the new financial year, the plan is to raise the level of customer service even higher and thereby increase the number of regular customers, which will result in sales growth.
Staff
The board of Krooniapteek OÜ consists of 1 member. No remuneration has been paid to the member of the board and no remuneration is foreseen for the recall or departure of the member of the board. The average number of employees converted to full-time in 2022 was 15. The total labor costs for the reporting year were 483.3 thousand EUR, of which direct wages accounted for 370.1 thousand EUR.
Key financial ratios
Financial ratios 2022 2021
Sales revenue, thousand EUR 4,971.10 4,537.20
EBITDA, thousand EUR 69.2 67.1 = Operating profit before depreciation
EBITDA margin, % 1.40% 1.50% = Operating profit before depreciation / Sales revenue
Net profit margin, % 1.50% 1.60% = Net profit / Sales revenue
Asset productivity, % 6.50% 9.10% = Net profit / Assets
Short-term liability coverage ratio 0.9 0.8 = Current assets / Short-term liabilities
Working capital, thousand EUR -52.4 -126.2 = Current assets - Short-term liabilities
Equity ratio, % 15.60% 13.20% = Equity / Total assets
Comments (0)